India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
Covered by 3 outlets: 1 lean left, 2 are centre.
Livemint Ophthalmic products recalled: Why drug regulators ordered Sun Pharma to halt eye-drop production at Assam plant?
Drug regulators flag failures in quality management system; Sun Pharmaceutical’s compliance report under review
Lean: Not rated Fact-focusedCountry: IndiaFunding: CorporateOwner: Independent
Reuters EXCLUSIVE: India orders Sun Pharma to halt eye-care drug production at plant after quality lapses - Reuters
EXCLUSIVE: India orders Sun Pharma to halt eye-care drug production at plant after quality lapses Reuters
Lean: Center Fact-focusedFactuality: Very highCountry: United KingdomFunding: CorporateOwner: Thomson Reuters
News India orders top drugmaker to halt eye medicine production at plant over quality lapses - CNA
India orders top drugmaker to halt eye medicine production at plant over quality lapses CNA EXCLUSIVE: India orders Sun Pharma to halt eye-care drug production at plant after quality lapses Reuters Sun Pharma taking...
Lean: Center Fact-focusedFactuality: Mostly factualCountry: IndiaFunding: CorporateOwner: Independent











